Muhammed Nurullah SABAZ, Alper AKIN, Meki BİLİCİ, Fikri DEMİR, Mehmet TÜRE, Hasan BALIK

Factors affecting mortality in children with dilated cardiomyopathy

Dilated cardiomyopathy (DCMP) is a heart disease with high mortality ratesthat is often seen in children. Genetic and infectious reasons are primary inthe etiology. The aim of this study was to investigate the etiology of DCMPand the parameters predicting mortality. A retrospective examination wasmade of 37 patients diagnosed with DCMP between January 2012 and October2016. Data were recorded from the patient files of age, gender, complaintson presentation, findings of the physical examination, laboratory test results,echocardiography and electrocardiography findings at the time of diagnosis.These parameters were then compared between the surviving and nonsurviving patients.The patients comprised 21 males with a mean age of 27.50±50 months.Diagnosis was made at the age of

PDF

___

1. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331: 1564-1575.

2. Nugent AW, Daubeney PE, Chondros P, et al; National Australian Childhood Cardiomyopathy Study. The epidemiology ofchildhood cardiomyopathy in Australia. N Engl J Med 2003; 348: 1639-1646.

3. Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet 2011; 375: 752-762.

4. Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol 1985; 6: 1126-1131.

5. Wilkinson JD, Sleeper LA, Alvarez JA, Bublik N, Lipshultz SE; The Pediatric Cardiomyopathy Study Group. The pediatric cardiomyopathy registry 1995- 2007. Prog Pediatr Cardiol 2008; 25: 31-36.

6. Den Boer SL, Meijer RP, van Iperen GG, et al. Evaluation of the diagnostic work-up in children with myocarditis and idiophathic dilated cardiomyopathy. Pediatr Cardiol 2015; 36: 409-416.

7. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985; 312: 885-890.

8. Moss and Adam’s Heart Disease In Infants, Children and Adolescents: Including the fetüs and young adult. Allen HD, Shaddy RE, Penny DJ, Cetta F, Feltes TF. In: Lin KY and Rossano JW, Dilated cardiomyopathy. by Volters Kluver (9th ed) 2016: 1283-1295.

9. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006; 296: 1867-1876.

10. Friedman RA, Moak JP, Garson A Jr. Clinical cause of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 1991; 18: 152-156.

11. Tsirka AE, Trinkaus K, Chen SC, et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol 2004; 44: 391-397.

12. Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 1998; 101(3 Pt 1): 369-376.

13. Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 1994; 72: 246- 250.

14. Aykan HH, Karagöz T, Akın A, İrdem A, Özer S, Çeliker A. Results of radiofrequency ablation in children with tachycardia-induced cardiomyopathy. Anatol J Cardiol 2014; 14: 625-630.

15. Nagarakanti R, Whellan D, Rubin S, Mather PJ. Reversible cardiomyopathies. Cardiol Rev 2007; 15: 178-183.

16. Baumert M, Czippelova B, Porta A, Javorka M. Decoupling of QT interval variability from heart rate variability with ageing. Physiol Meas 2013; 34: 1435- 1448.

17. Alonso JL, Martínez P, Vallverdú M, et al. Dynamics of ventricular repolarization in patients with dilated cardiomyopathy versus healthy subjects. Ann Noninvasive Electrocardiol 2005; 10: 121-128